|Articles|April 1, 2022

LCGC Supplements

  • Recent Developments in Biopharmaceutical Analysis
  • Volume 40
  • Issue s4

Recent Developments in Biopharmaceutical Analysis European PDF

Click the image below to access the LCGC Europe Supplement 'Recent Developments in Biopharmaceutical Analysis'

Articles in this issue

over 3 years ago

State-of-the-Art Biopharmaceutical Analysis

over 3 years ago

Improving Selectivity in the Chromatographic Analysis of Monoclonal Antibodies (mAbs) Through the Use of Multi-Isocratic Elution Mode

over 3 years ago

Analytical Applications of Immobilized Enzyme Reactors (IMERs) Coupled to LC–MS/MS for Bottom- and Middle-Up Characterization of Proteins

over 3 years ago

The Power of Trypsin Immobilized Enzyme Reactors (IMERs) Deployed in Online MDLC–MS Applications

over 3 years ago

Online HPLC–HRMS Platform: The Next-Generation Process Analytical Technology Tool for Real-Time Monitoring of Antibody Quality Attributes in Biopharmaceutical Processes

over 3 years ago

Multi-Attribute Monitoring and the Multi-Attribute Method: A Powerful Double Act for Supporting Biopharmaceutical Manufacturing

over 3 years ago

New Aspects in the Integration of MS Technologies in the Biopharmaceutical Industry

over 3 years ago

Perspectives on the Use of Retention Modeling to Streamline 2D-LC Method Development: Current State and Future Prospects

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe Now!
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us